References
Products Transfection
Free Sample Offer
Instruction for Use:
In the „Transfection Reagent Selection Guide“ you can find existing references by setting different filters e.g. for your combination of nucleic acid and cell type. Appropriate keywords in the “Search references“ at the top of the page can also yield a result. A reference indicates that the found transfection reagent has been successfully used for the corresponding application. Ideally, tested transfection parameters and transfection efficiencies are specified.
No reference? > General Selection Guide
If the list does not include a reference concerning your cell type, this does not mean that there is no suitable reagent available, but only that there is no report of experiences with this cell type. In this case it is necessary to preselect (General Selection Guide) and test a reagent (Free Sample Offer). If you want to write an application note for us we will make you an Offer for consideration.
| CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Human immortalized lymphocyte cell line (immortalized by EBV) | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | M. Pradas-Juni et al., Mol. Endocrinoly, 2014, 28(9): 1558-1570, doi: 10.1210/me.2014-1065 | Link | |||
| Human primary chronic lymphocytic leukemia cells | Human | immune system | primary cell | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Haematologica, Jul 2008; 93: 1039 - 1048 | Link | |||
55.1 |
Human immortalized cord blood | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | |
||||
55.2 |
Human immortalized cord blood | ATCC CRL-2155 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | |
|||
CD4+ T cells |
Human CD4+ T cells | Human | immune system | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | J.-S. Chung et al., Eur. J. Immunol., 2011,41: 1794–1799, DOI 10.1002/eji.201041233 | ||||
DG-75 |
Human Burkitt's lymphoma cell line | ATCC CRL-2625 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | S. Thakker et al., J. Virol., May 2015; 89: 5536 - 5556 | |||
hADMC |
Human primary adipose-derived mast cells | Human | immune system | primary cell | plasmid | Metafectene PRO | publication | M. Motaghed et al., J. Immuntherapy of Cancer, 2021, 9(Suppl 2): A1–A1052, doi.org/10.1136/jitc-2021-SITC2021.220 | Link | ||||
hHSC |
Human hematopoietic stem cells (CD34+) | Human | immune system | stem cell | suspension | plasmid | K2 Transfection System | application note | |
||||
HL-60 |
Human adult acute myeloid leukemia cell line | ATCC CCL-240 | Human | immune system | cell line | suspension | plasmid | Metafectene EASY | publication | J. C. Romero Sandoval, PhD Thesis, 2014, Universitat de Barcelona | Link | ||
HL-60 |
Human adult acute myeloid leukemia cell line | ATCC CCL-240 | Human | immune system | cell line | suspension | siRNA | RNA-Interference | Metafectene PRO | publication | B. Landry et al., PLoS ONE, 2012, 7(8): e44197, doi:10.1371/journal.pone.0044197 | Link | |
hMDM |
Human monocyte-derived macrophages | Human | immune system | unknown | adherent | oligonucleotide | K2 Transfection System | application note | |
||||
hMDM |
Human monocyte-derived macrophages | Human | immune system | unknown | adherent | plasmid | Metafectene EASY | publication | J. C. Romero Sandoval, PhD Thesis, 2014, Universitat de Barcelona | Link | |||
hMDM |
Human primary monocyte-derived macrophages | Human | immune system | primary cell | siRNA | RNA-Interference | Metafectene | publication | M. P. Morrow et al., Mol. Pharmacol., Aug 2010; 78: 215 - 225 | Link | |||
HPBL |
Human primary peripheral blood lymphocytes | Human | immune system | primary cell | suspension | siRNA | RNA-Interference | Metafectene | publication | S. Romano et al., Haematologica, Jul 2008; 93: 1039 - 1048 | Link | ||
hPBMC |
Human primary peripheral blood mononuclear cells | Human | immune system | primary cell | suspension | plasmid | Metafectene | publication | S. Smith, PhD Thesis, 2013, Royal College of Surgeons in Ireland | Link | |||
hPBMC |
Human primary peripheral blood mononuclear cells | Human | immune system | primary cell | suspension | plasmid | Metafectene SI | publication | S. Smith, PhD Thesis, 2013, Royal College of Surgeons in Ireland | Link | |||
hPBMC |
Human peripheral blood monocyte-derived macrophages | Human | immune system | primary cell | siRNA | RNA-Interference | K2 Transfection System | publication | D. Pires et al., Scientific Reports, 2016, 6:32247, DOI: 10.1038/srep32247 | Link | |||
iDC |
Human immature dentritic cells | Human | immune system | primary cell | plasmid | Metafectene | publication | Z. K. Nazarkina et al., Mol. Biology, 2018, 52(2): 222–231, DOI: 10.1134/S0026893317050132 | |||||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | V. Witte et al., J. Immunol., Dec 2008; 181: 8425 - 8432 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | cotransfection (plasmid/plasmid) | K2 Transfection System | publication | K. Marek-Bukowiec et al., Genes and Immunity, 2016, 17: 313-320, doi:10.1038/gene.2016.25 | Link | |
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene | publication | Q. Chen et al., J. Biol. Chem., Jul 2006; 281: 19985 - 19994 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | application note | |
|||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | A. K. V. Iyer et al., J. Immunol., 2011, 187(6): 3256–3266, doi:10.4049/jimmunol.1002915. | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | plasmid | Metafectene PRO | publication | A. K. V. Iyer et al., J. Immunol., Sep 2011; 187: 3256 - 3266 | Link | ||
Jurkat |
Human leukemia T-cell line | ECACC 88042803 | Human | immune system | cell line | suspension | oligonucleotide | DOTAP | publication | A. Avinó et al., Protocols in Nucleic Acid Chemistry, 2020, 77: e78, doi: 10.1002/cpnc.78 |









